Don’t miss the final Plenary Sessions, Poster Sessions, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.

Don’t miss a Plenary Session on early-onset cancers, sessions on precision oncology and immunotherapy strategies, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.

The first of two Plenary Sessions on Wednesday will convene leading experts who are advancing radioligand therapy, antibody-drug conjugates (ADCs), T‑cell engagers, and tumor‑infiltrating lymphocyte (TIL) therapy.

A final Plenary Session on Wednesday afternoon will offer a unique opportunity for attendees to learn about some of the biggest advances reported at the meeting across the continuum of cancer research.

On Tuesday evening, four field-defining researchers will cover multiomics approaches to cancer classification, tumor and immune-cell dynamics, strategies for overcoming drug resistance in clinical trials, and telomere targeting.

Don’t miss a morning Plenary Session on advances in artificial intelligence, an afternoon address by NCI Director Anthony G. Letai, MD, PhD, FAACR, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.

The fourth Plenary Session will integrate population trends, etiologic clues, tumor biology, and real‑world outcomes to discuss potential causes and actionable opportunities for prevention.

On Monday, two cancer research luminaries will discuss strategies for integrating both molecular and digital pathology and work on how neutrophils are reprogrammed on behalf of cancer within the tumor microenvironment.

A Tuesday session will include specially selected presentations from the most recent San Antonio Breast Cancer Symposium (SABCS), an international forum for foundational discoveries in breast cancer that is cosponsored by the AACR.

Don’t miss the Opening Ceremony and Opening Plenary, the first New Drugs on the Horizon sessions, and more, say Program Committee Chairs Paul S. Mischel, MD, FAACR, and Alice T. Shaw, MD, PhD, FAACR.